Peptides Are Exploding. Payments Isn’t Ready
Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrit...
The intersection of workplace safety and cannabis legalization presents one of the most pressing challenges for employers in 2024, driven by the limitations of traditional drug testing methods and the need for more accurate impairment detection. In a recent Qredible Live webinar, Ken Fichtler, founder and CEO of Gaize, joined Qredible CEO and Chairman Brian Fitzpatrick to discuss how eye-movement technology can support safe cannabis legalization.
Their conversation highlighted a critical challenge facing the industry. According to Fichtler, approximately 22% of Americans have used cannabis in the past year, making it essential for businesses to find ways to maintain workplace safety while fairly employing cannabis users in states where it's legal.
Traditional THC testing methods have created a significant dilemma for employers. As Fichtler explains, "You can be positive on a urinalysis screening for weeks or positive on an oral fluid saliva test for a couple days," making it impossible to distinguish between recent use and legal off-duty consumption.
This fundamental disconnect has forced many businesses to abandon THC testing altogether, creating a challenging balance between maintaining adequate staffing and ensuring workplace safety. This challenge led Fichtler and his team to develop an innovative solution: eye-movement analysis technology that can detect current impairment rather than just past use.
The technology conducts six different eye movement tests, mirroring methods used by drug recognition expert police officers. "What's great about our technology," Fichtler explains, "is that understanding eye movement is very predictive of what's happening in the brain, so we have a direct line of communication and understanding to where the body is and how it's responding."
These tests have been validated in courts across nearly all 50 states, providing a reliable foundation for workplace implementation. Unlike chemical tests, eye-movement analysis identifies current impairment rather than just detecting THC presence in the system.
The implementation of eye-movement technology is providing businesses with multiple advantages, creating measurable improvements in both operational efficiency and risk management:
As Fichtler notes, "We have quite a number of Fortune 500 companies that are using our products today," demonstrating how mainstream businesses are adopting this technology to create safer, more efficient workplaces.
According to Fichtler, cannabis impairment manifests in several measurable ways that affect workplace performance and safety:
"There's this pervasive opinion that people are safer drivers when they're high or that they're safer workers when they're high, and that's just simply not true," explains Fichtler, emphasizing the importance of recognizing these impairment effects in workplace settings.
As cannabis legalization expands, businesses need reliable methods to ensure workplace safety while respecting employees' legal right to use cannabis during personal time.
Eye-movement technology provides this balance by focusing on current impairment rather than past use. This approach allows employers to maintain safety standards without penalizing employees for legal off-duty cannabis use.
Adopting eye-movement technology for impairment detection marks a crucial advancement in workplace safety protocols. "What our product does is it allows them to detect current impairment or impairment as it's being experienced rather than just prior use," Fichtler explains.
By providing accurate, real-time impairment detection, businesses can better protect their workforce while adapting to changing cannabis laws. This technology offers a practical solution for maintaining both safety and fairness in the modern workplace.
